M G Masucci - JoVE Visualize

Showing results (61-70 of 121) with videos related to

Pageof 13

Sort By:

FEBS Letters|January 1, 1999

Random coil conformation of a Gly/Ala-rich insert in IkappaB alpha excludes structural stabilization as the mechanism for protection against proteasomal degradationA Leonchiks, E Liepinsh, M Barishev, et al.

International Journal of Cancer|July 30, 1992

Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma lineL Cuomo, T Ramquist, P Trivedi, et al.

Cellular and Molecular Life Sciences : CMLS|February 28, 2006

The ubiquitin-specific protease USP25 interacts with three sarcomeric proteinsA Bosch-Comas, K Lindsten, R Gonzàlez-Duarte, et al.

Journal of Immunological Methods|January 1, 1982

Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytesY Wu, I Ernberg, M G Masucci, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998

Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexesV Levitsky, Q J Zhang, J Levitskaya, et al.

Human Immunology|November 18, 2000

Supermotif peptide binding and degeneracy of MHC: peptide recognition in an EBV peptide-specific CTL response with highly restricted TCR usageV Levitsky, D Liu, S Southwood, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987

Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma linesM G Masucci, S Torsteindottir, J Colombani, et al.

FEBS Letters|February 19, 1998

High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexesR Gavioli, R Guerrini, M G Masucci, et al.

European Journal of Immunology|October 1, 1990

Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte culturesL Cuomo, P Trivedi, F Wang, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytesJ Avila-Cariño, S Torsteinsdottir, B Ehlin-Henriksson, et al.

Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:

Pageof 13

FEBS Letters|January 1, 1999

Random coil conformation of a Gly/Ala-rich insert in IkappaB alpha excludes structural stabilization as the mechanism for protection against proteasomal degradationA Leonchiks, E Liepinsh, M Barishev, et al.

International Journal of Cancer|July 30, 1992

Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma lineL Cuomo, T Ramquist, P Trivedi, et al.

Cellular and Molecular Life Sciences : CMLS|February 28, 2006

The ubiquitin-specific protease USP25 interacts with three sarcomeric proteinsA Bosch-Comas, K Lindsten, R Gonzàlez-Duarte, et al.

Journal of Immunological Methods|January 1, 1982

Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytesY Wu, I Ernberg, M G Masucci, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998

Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexesV Levitsky, Q J Zhang, J Levitskaya, et al.

Human Immunology|November 18, 2000

Supermotif peptide binding and degeneracy of MHC: peptide recognition in an EBV peptide-specific CTL response with highly restricted TCR usageV Levitsky, D Liu, S Southwood, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987

Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma linesM G Masucci, S Torsteindottir, J Colombani, et al.

FEBS Letters|February 19, 1998

High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexesR Gavioli, R Guerrini, M G Masucci, et al.

European Journal of Immunology|October 1, 1990

Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte culturesL Cuomo, P Trivedi, F Wang, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytesJ Avila-Cariño, S Torsteinsdottir, B Ehlin-Henriksson, et al.

Pageof 13